Intas Pharmaceuticals Limited, a active public limited company, was established on 31 May 1985 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1985PLC007866. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹175.47 Cr and a paid-up capital of ₹114.77 Cr.
Formerly known as Intas Laboratories Private Limited. It upholds a compliant status. Employing 19,974 professional, Its leadership includes Urmish Hasmukh Chudgar (Managing Director), Hasmukh Chudgar (Director), Archana Ravindrarai Dholakia (Director). Past directors included Hemant Devidas Sheth, Kusumben Hasmukhbhai Chudgar, Sanjiv Dwarkanath Kaul. It holds ₹4.50 Cr open charges and ₹7,924.94 Cr settled loans. Its latest AGM occurred on 08 September 2025, with the balance sheet filed on 31 March 2025. It is based at Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad, Gujarat, 380054.
U24231GJ1985PLC007866
007866
31 May 1985
₹175.47 Cr
₹114.77 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Intas Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Urmish Hasmukh Chudgar | Managing Director | 30 Sep 1996 | Current |
| Hasmukh Chudgar | Director | 31 May 1985 | Current |
| Archana Ravindrarai Dholakia | Director | 14 Jun 2023 | Current |
| Jayesh Shantilal Shah | Whole-Time Director | 21 Mar 2018 | Current |
| Venkatesh Ratnasami | Nominee Director | 13 Nov 2014 | Current |
| Binish Hasmukh Chudgar | Managing Director | 31 May 1985 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 10 Aug 2015 | Past |
| Pramod Abcsdd | Nominee Director | 13 Jan 2020 | Past |
| Pramod Abcsdd | Whole-Time Director | 11 Mar 2015 | Past |
| Pramod Abcsdd | Cfo(Kmp) | 30 Nov 2022 | Past |
| Pramod Abcsdd | Additional Director | 12 Aug 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Intas Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.44% decrease. The company also saw a substantial fall in profitability, with a 17.74% decrease in profit. The company's net worth Soared by an impressive increase of 13.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Intas Pharmaceuticals had a promoter holding of 83.84% and a public holding of 16.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹45,000,000.00
₹79,249,379,660.29
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 May 1998 | Dena Bank | ₹4.50 Cr | Open |
| 04 Sep 2017 | Standard Chartered Bank | ₹184.62 Cr | Satisfied |
| 28 Dec 2016 | Others | ₹1,845.87 Cr | Satisfied |
| 28 Dec 2016 | Others | ₹3,218.29 Cr | Satisfied |
| 21 Mar 2016 | Citi Bank N.A. | ₹115.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Intas Pharmaceuticals has a workforce of 19974 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Intas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Intas Pharmaceuticals Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records. was documented.
Intas Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
The activity Rakesh Bamzai was appointed as a CEO was appointed as a CEO on 11 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
The activity Abhimanyu Ojha was appointed as a Cfo was appointed as a Cfo on 11 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
The activity A charge registered on 25 Jun 1999 via Charge ID 90103163 with Others was fully satisfied on 01 Oct 2024. was completed.
The activity Jitesh Kishorekumar Gadhia was appointed as a Additional Director was appointed as a Additional Director on 19 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
The CIN of Intas Pharmaceuticals Limited is U24231GJ1985PLC007866.
Intas Pharmaceuticals Limited is headquartered at Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad, Gujarat, 380054.
Intas Pharmaceuticals Limited was incorporated on 31 May 1985.
The current directors of Intas Pharmaceuticals Limited are
The primary industry of Intas Pharmaceuticals Limited is Manufacturing.
Intas Pharmaceuticals Limited is unlisted.
The authorized capital of Intas Pharmaceuticals Limited is ₹175.47 Cr, and the paid-up capital is ₹114.77 Cr.
The compliance status of Intas Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX